位置:成果数据库 > 期刊 > 期刊详情页
Baicalin Attenuates Focal Cerebral Ischemic Reperfusion Injury by Inhibition of Protease-Activated Receptor-1 and Apoptosis
  • 分类:Q95-33[生物学—动物学] Q631[生物学—生物物理学]
  • 作者机构:[1]Department of Neurology, The Second Hospital, Shandong University, Jinan (250033), China, [2]Shandong University School of Medicine, Jinan (250012), China, [3]Department of Experimental Pathology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan (250012), China, [4]China Institute of Pharmacology, College of Medicine, Shandong University, Jinan (250012), China, [5]Department of Gerontology, Qilu Hospital, Shandong University, Jinan (250012), China
  • 相关基金:Supported by National Natural Science Foundation of China (No. 81072916), Shandong Science and Technique Foundation (No. 2005GG3202062), Shandong Traditional Chinese Medicine Administration Fund Program (No.2009-160) and Free Exploration Program of Shandong University (No.2009TS009)
中文摘要:

目的将与焦点的服的 ischemic 灌注损害在 Wistar 老鼠调查 baicalin 的 neuro 保护的效果。称 320350 g 的 90 只成年男 Wistar 老鼠随机被划分成下列组(n=5 ) 的方法:(a) 假冒的控制组;(b) 车辆组,使遭到了到中间的服的动脉吸藏并且 intraperitoneally 收到了车辆;(c-e ) baicalin 组织 25, 50 和 100,它受到中间的服的动脉吸藏并且与 baicalin 对待 mg/kg 分别地。神经病学的分数被决定在手术后在处理以后的 1, 3 和 7 d。激活朊酶的 receptor-1 (PAR-1 ) 的表示, PAR-1 mRNA 和 Caspase-3 分别地用西方的污点,反向的抄写聚合酶链反应(RTPCR ) 分析和 immunohistochemistry 被决定。结果重要减少与车辆组的相比在 baicalin 组在神经病学的分数被注意(P < 0.01 ) 。另外, PAR-1 mRNA, PAR-1 和 Caspase-3 的下面规定与从车辆组获得的那些相比在 baicalin 组被观察(P < 0.01 ) 。与低剂量的 baicalin 组(25 mg/kg ) 相比,显著减少在高剂量的组在 PAR-1 mRNA, PAR-1 以及 Caspase-3 的神经病学的分数,和表示被注意(P < 0.05 ) 。结论 Baicalin 通过禁止 PAR-1 和 apoptosis 的表示在焦点的服的 ischemic 灌注损害显示出 neuro 保护的效果。

英文摘要:

Objective: To investigate the neuro-protective effects of baicaiin in Wistar rats with focal cerebral ischemic reperfusion injury. Methods: Ninety adult male Wistar rats weighing 320-350 g were randomly divided into the following groups (n=5): (a) sham control group; (b) vehicle group, subjected to middle cerebral artery occlusion and received vehicle intraperitoneally; (c-e) baicalin groups, which were subjected to the middle cerebral artery occlusion and treated with baicalin 25, 50 and 100 mg/kg, respectively. The neurological scores were determined at postoperative 1, 3 and 7 d after the treatment. The expression of protease-activated receptor-1 (PAR-1), PAR-1 mRNA and Caspase-3 were determined using Western blot, reverse transcription polymerase chain reaction (RT- PCR) analysis and immunohistochemistry, respectively. Results: Significant decrease was noted in the neurological score in the baicalin group compared with that of the vehicle group (P〈0.01). Additionally, down-regulation of PAR-1 mRNA, PAR-1 and Caspase-3 was observed in the baicalin groups compared with those obtained from the vehicle group (P〈0.01). Compared with the low-dose baicalin group (25 mg/kg), remarkable decrease was noted in neurological score, and the expression of PAR-1 mRNA, PAR-1 as well as Caspase-3 in the high-dose group (P〈0.05). Conclusion: Baicalin showed neuro-protective effects in focal cerebral ischemic reperfusion injury through inhibiting the expression of PAR-1 and apoptosis.

同期刊论文项目
同项目期刊论文